NCT04985357 2024-11-25Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsTravera IncWithdrawn
NCT05819580 2023-04-25Studying the Clinical Trial Experiences of Patients With MesotheliomaPower Life Sciences Inc.Not yet recruiting500 enrolled
NCT01271959 2012-10-05A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry StudyPrecision TherapeuticsTerminated167 enrolled